课题基金 / 基金详情

National HIV Behavioral Surveillance, Los Angeles County

National HIV Behavioral Surveillance, Los Angeles County
洛杉矶县国家艾滋病毒行为监测
批准号:
8121271
负责人:
Trista A. Bingham
金额:
$62.45万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-01-01 至 2015-12-31

项目摘要

项目成果

Trista A. Bingham的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):为了监测HIV危险行为的流行率、HIV感染以及在HIV高危人群中使用HIV预防计划的情况,洛杉矶县公共卫生部(LACDPH)HIV流行病学计划建议在2011-2015年间实施HIV行为监测系统。该系统将对男男性行为者(MSM)、注射吸毒者(IDU)和有艾滋病毒感染风险的异性恋者(HET)进行交替横断面调查,使用基于场地和受访者驱动的抽样方法。收集的行为数据将用于为地方艾滋病毒预防规划提供信息,并为国家艾滋病毒行为监测(NHBS)数据库做出贡献。这项提案的总体目标是维持我们的NHBS系统,以监测洛杉矶县高危人群中艾滋病毒危险行为的长期趋势。此外,我们还提议开展三项补充研究活动,使我们能够a)在第三个男男性接触者周期中帮助开发新的艾滋病毒检测技术;b)估计男男性接触者、静脉注射吸毒者和HET人群中乙肝和丙型肝炎的流行率;以及c)进行一个周期的NHBS,所有种族/民族的至少200名男性到女性变性人(TG)。为了实现这些目标,我们确定了以下具体目标:1.开展年度行为调查。我们将通过在洛杉矶县六个NHBS周期内对有艾滋病毒感染风险的MSM、IDU、异性恋和男性到女性变性人进行标准化问卷调查,监测艾滋病毒危险行为的流行情况以及艾滋病毒预防计划的获得和使用。2.提供艾滋病毒、乙肝和丙型肝炎检测。我们将向NHBS参与者提供快速和标准的艾滋病毒检测服务,并使用这些结果数据来估计艾滋病毒的流行率和发病率。我们还将提供筛查测试,以检测五个NHBS周期内的乙肝和丙型肝炎感染证据,并在NHBS-MSM3期间参与开发新的艾滋病毒检测技术。3.与当地合作伙伴合作。我们将让当地研究人员参与定性研究活动,并将与当地社区机构合作,共同制定当地使用的调查问题和实施战略。4.对NHBS系统进行评估。我们将与疾控中心合作,监测当地NHBS数据收集和实施方法的质量、效率和价值。
英文摘要
DESCRIPTION (provided by applicant): To monitor the prevalence of HIV risk behaviors, HIV infection, and the use of HIV prevention programs among populations at increased risk for HIV, the Los Angeles County Department of Public Health's (LACDPH) HIV Epidemiology Program proposes to implement an HIV behavioral surveillance system during 2011-2015. The system will involve alternating cross-sectional surveys among men who have sex with men (MSM), injecting drug users (IDU), and heterosexuals at risk for HIV infection (HET) using both venue-based and respondent- driven sampling methods. The collected behavioral data will be used to inform local HIV prevention planning as well as to contribute to a national HIV behavioral surveillance (NHBS) database. The overall goal of this proposal is to maintain our NHBS system for monitoring long-term trends in HIV risk behaviors among high-risk populations in Los Angeles County. In addition, we are proposing three supplemental research activities that will allow us to a) help develop new HIV-testing technologies during our third MSM cycle; b) estimate the prevalence of hepatitis B and C in MSM, IDU, and HET populations; and c) conduct one cycle of NHBS with a minimum of 200 male-to-female transgender persons (TG) of all races/ethnicities. To accomplish these goals, we have identified the following specific aims: 1. Conduct annual behavioral surveys. We will monitor the prevalence of HIV risk behaviors and access to and use of HIV prevention programs by administering standardized questionnaires among MSM, IDU, heterosexual, and male-to-female transgender persons at risk of HIV infection across six NHBS cycles in Los Angeles County. 2. Offer HIV and hepatitis B and C testing. We will provide rapid and standard HIV testing services to NHBS participants and use these outcome data to estimate HIV prevalence and incidence. We will also offer screening tests to detect evidence of hepatitis B and C infection across five NHBS cycles and offer participation in developing new HIV testing technologies during NHBS-MSM3. 3. Collaborate with local partners. We will engage local researchers in qualitative research activities and we will work with local community agencies to co-develop local-use survey questions and implementation strategies. 4. Evaluate the NHBS system. We will work collaboratively with CDC to monitor the local quality, efficiency, and value of NHBS data collection and implementation methods.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PS11-001: National HIV Behavioral Surveillance, Los Angeles County
National HIV Behavioral Surveillance, Los Angeles County
PS09-007 Evaluating Locally-Developed Homegrown HIV Prevention Interventions
PS09-007 Evaluating Locally-Developed Homegrown HIV Prevention Interventions
国内基金
海外基金
人类免疫缺陷病毒(HIV)总核酸检测试剂盒
基于深度测序与SNV 芯片的HIV重复感染与毒株重组机制研究
  • 批准号:
    2026JJ81281
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    徐艳
  • 依托单位:
HIV相关肺癌免疫微环境中关键免疫细胞亚群的功能特征与调控机制研究
PGT123中和抗体修饰的工程化载肽囊泡疫苗通过诱导CD4+ T细胞极化在抗HIV感染中的应用和机制研究